Left Irdes in December 2012
The Impact of the Long-term Illness Scheme (LTI) on Inequalities in the Utilisation of Ambulatory Care Between 1998 and 2008
Dourgnon P. (Irdes ; Université Paris-Dauphine, Leda-Legos), Or Z. (Irdes), Sorasith C. (Irdes)
Issues in Health Economics (Questions d'économie de la santé) n° 183. 2013/01.
How to Explain Price Gaps between Me-too Drugs?
A 2001-2009 Panel-data Analysis
Bergua L. (CHU de Rouen), Cartier T. (Université Paris Diderot, Sorbonne Paris Cité, Irdes), Célant N. (Irdes), Pichetti S. (Irdes), Sermet C. (Irdes), Sorasith C. (Irdes)
Issues in Health Economics (Questions d'économie de la santé) n° 178. 2012/07-08.
Analysis of the impact of removing mucolytics and expectorants from the list of reimbursable drugs on presciption rates: A time-series analysis for France 1998-2010.
Pichetti S., Sorasith C., Sermet C., Health Policy, vol.102, issues 2-3, 2011/10, 159-169.
(Catégorie 2 - CNRS) - (Cat. A - Hcérès)
Arammis Microsimulation Model Contribution: an Analysis of the Redistributive Effects of an OOP Maximum on Ambulatory Care Expenditures
Debrand T., Sorasith C.
Issues in Health Economics (Questions d'économie de la santé) n° 159. 2010/11
Out-of-Pocket Maximum Rules under a Compulsory Health Care Insurance Scheme:
A Choice between Equality and Equity
Debrand T. (Irdes), Sorasith C. (Irdes)
Working paper n° 34. 2010/11